Insider Trading Activity For Catalyst Pharmaceuticals Inc (NASDAQ:CPRX)
Donald A Denkhaus , Director of Catalyst Pharmaceuticals Inc (NASDAQ:CPRX) reportedly Bought 20,000 shares of the company’s stock at an average price of 3.75 for a total transaction amount of $75,000.00 SEC Form
Insider Trading History For Catalyst Pharmaceuticals Inc (NASDAQ:CPRX)
Analyst Ratings History For Catalyst Pharmaceuticals Inc (NASDAQ:CPRX)
- On 11/1/2017 Roth Capital Set Price Target of rating Buy with a price target of $5.00
- On 11/29/2017 SunTrust Banks Reiterated Rating Buy with a price target of $6.00
- On 12/1/2017 Piper Jaffray Companies Set Price Target of rating Positive ➝ Buy with a price target of $8.00
- On 3/15/2018 HC Wainwright Reiterated Rating Buy with a price target of $6.00
Recent Trading Activity for Catalyst Pharmaceuticals Inc (NASDAQ:CPRX)
Shares of Catalyst Pharmaceuticals Inc closed the previous trading session at 3.92 up +0.09 2.35% with 3.809999942779541 shares trading hands.